Phase 1 Study of Low Level Laser Therapy Versus Naproxen
Overview
- Phase
- Phase 1
- Intervention
- low level laser therapy
- Conditions
- TMD
- Sponsor
- Shahid Beheshti University
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- reduction of paim measured by VAS
- Last Updated
- 13 years ago
Overview
Brief Summary
tempromandibuar disorders are a group of heterogenous pathologies affecting temporomandibular joint,muscles or both.in more than 90%of cases muscles are the origin of pain.TMDs cause pain,movement disability and deficit in quality of life.in more than 90%of cases pain is the major complaint.we run this investigation to find the analgesic effct of low level laser therapy versus pharmacotherapy with naproxen in improving pain.
Investigators
saranaz azari-marhabi
oral medicine resident
Shahid Beheshti University
Eligibility Criteria
Inclusion Criteria
- •patients with TMD affecting masticatory muscles
Exclusion Criteria
- •systemic disease
- •GI problem
- •pregnancy
- •epidermal cancer
Arms & Interventions
Low level laser therapy
this arm recieves low level laser therapy treatment for 12 sessions.
Intervention: low level laser therapy
naproxen
this arm takes naproxen 500 mg twice daily for 3weeks
Intervention: Naproxen
Outcomes
Primary Outcomes
reduction of paim measured by VAS
Time Frame: 1 month
VAS is visual analogue scale